August 14, 2018 12:44 pm
Updated: August 14, 2018 1:32 pm

Congo tests experimental Ebola treatment as deadly outbreak grows

WATCH ABOVE: Ebola kills 41 in Congo and infects 7 health care workers, WHO says


GOMA, Democratic Republic of Congo, Aug 14  РDemocratic Republic of Congo has started using the experimental mAb114 Ebola treatment on patients in the east of the country, the health ministry said on Tuesday, the first time it has been deployed against an active outbreak.

READ MORE: 2 Ebola patients die after escaping quarantine in Congo

The outbreak in eastern Congo’s North Kivu province has now spread to neighbouring Ituri province, where a person who was a confirmed case died after returning home from the flare-up’s epicentre in the North Kivu town of Mangina, the ministry said in a statement.

Five new cases have been confirmed, the statement said, bringing the total number of cases to 57 — 30 confirmed and 27 that are considered probable. Forty-one people are believed to have died in all from the hemorrhagic fever.

WATCH: Congo starts using experimental Ebola treatment

The mAb114 treatment was developed in the United States by the National Institutes of Health using the antibodies of the survivor of an Ebola outbreak in the western Congolese city of Kikwit in 1995.

It was 100 per cent effective when tested on monkeys.

READ MORE: This ‘lucky mistake’ from a Winnipeg lab is saving people from Ebola in the Congo

The ministry said that several other experimental treatments have arrived in the regional hub of Beni and are awaiting approval from an ethics committee, including Remdesivir , Favipiravir and REGN3450, REGN3471 and REGN3479.

— Reporting By Fiston Mahamba; Writing by Aaron Ross; Editing by Catherine Evans

© 2018 Thomson Reuters

Report an error


Want to discuss? Please read our Commenting Policy first.